Results 331 to 340 of about 12,292,416 (404)

Association of antipsychotic drug target genes and risk of lung cancer: a Mendelian randomization study. [PDF]

Discov Oncol
Xiang J, Xiang G, Zhan M, Zhang L, Zeng H, Song X.   +5 more
europepmc   +1 more source

Exploiting similarity in drug molecular effects for drug repurposing. [PDF]

Hum Genomics
Huang K, Lalagkas PN, Sultan B, Melamed R.   +3 more
europepmc   +1 more source

Platforms, risk perceptions, and reporting: the impact of illicit drug advertisements on social media among UK secondary students. [PDF]

Harm Reduct J
Fuller A, Vasek M, Mariconti E, Johnson SD.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs

Recent Patents on CNS Drug Discovery, 2015
With the advances in antiretroviral (ARV) therapy, patients with Human Immunodeficiency Virus (HIV) infection are living longer, however, some patients encounter co- morbidities which sometimes require treatment. Therefore, during the treatment with ARV drugs these patients could take several recreational drugs (e.g.
Antonio Siniscalchi, Benedetto Caroleo, Luca Gallelli, Orietta Staltari, Emilio Russo, Christian Leporini, Giovambattista De Sarro   +6 more
openaire   +3 more sources

Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs

Antiviral Therapy, 2005
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) provide a framework for the implementation of TDM in certain defined scenarios in clinical practice. However, the utility of TDM
Boffito, M, Acosta, E, Burger, D, Fletcher, C, Flexner, C, Garaffo, R, Gatti, G, Kurowski, M, PERNO, CARLO FEDERICO, Peytavin, G, Regazzi, M, Back, D.   +11 more
openaire   +5 more sources

Monitoring of Drug-Drug and Drug-Food Interactions

American Journal of Health-System Pharmacy, 1988
A program for detecting and preventing potentially serious drug-drug and drug-food interactions is described. Two clinical pharmacists developed drug interaction alert (DIA) cards for each potential interaction to be monitored. The cards contain information about the proposed mechanism and potential result of the interaction, as well as information ...
Susan M. Garabedian-Ruffalo, Patricia M. Lanius, Antoinette Plucinski, Margo Syrja-Farber   +3 more
openaire   +3 more sources

Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs

The American Journal of Medicine, 1986
Nonsteroidal anti-inflammatory drugs may cause a number of drug interactions. They can displace other drugs from serum proteins, and some can affect the metabolism or decrease the renal elimination of other drugs. In addition, they can attenuate the pharmacologic effect of other drugs, such as diuretic and antihypertensive agents, without affecting ...
John H. Greist, Margaret Baudhuin, James W. Jefferson, Judith A. Carroll   +3 more
openaire   +6 more sources

Drug delivery

Drug Discovery Today, 2001
Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance and biological relevance of new molecules reported in the
openaire   +6 more sources